BioPharma Drug Discovery

Asieris Pharmaceuticals and Theramex Sign Over $250 Million Licensing Deal for Cervical Precancer Therapy CEVIRA

Agreement is expected to grant Theramex exclusive rights to CEVIRA® in Europe, Australia, New Zealand and Turkey, while Asieris retains rights for th...

 October 13, 2026 | News

Rockwell Automation Joins Digital CMC Consortium to Accelerate Drug Development and Pharmaceutical Manufacturing

Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, announced it is a fo...

 October 13, 2026 | News

12 APAC-Originated Programmes to Watch at ESMO 2026

When the ESMO Congress 2026 opens at IFEMA Madrid on Friday 23 October, the region that most European oncologists still think of as a fast follower will ho...

 October 13, 2026 | News

GenScript and NVIDIA Launch Global PitchFest to Accelerate AI-Driven Drug Discovery Startups

GenScript Biotech Corporation announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition for startups applying arti...

 October 12, 2026 | News

Semaglutide Generics, Six Months In: Every Launch in India, Every Price, and Where China Stands

AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials...

 October 09, 2026 | Analysis

XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery

This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property...

 October 08, 2026 | News

QIAGEN Expands AI Push with New Tools for Biological Research and Drug Discovery

New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN D...

 October 08, 2026 | News

Thermo Fisher Proteomics Study Uncovers Over 2,500 New Genetic-Protein Associations

Thermo Fisher’s complementary proteomic technologies uncovered more than 2,500 new biological associations: Initial findings from the PRECISE-SG100...

 October 06, 2026 | News

CSL, Alentis Forge $1.55B Partnership to Advance Lixudebart for Kidney and Liver Diseases

Alentis to receive US$355 million initial payment and up to US$1.2 billion in commercial milestones, with global profits shared CSL and Alentis Therapeuti...

 October 06, 2026 | News

FDA Expands Lilly’s Jaypirca Approval to First-Line CLL/SLL Treatment

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirto...

 October 06, 2026 | News

Rznomics Secures Positive EMA Opinion for Orphan Designation of RZ-001 in Glioma

Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the European Medicines Agency's (EMA...

 October 02, 2026 | News

Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing

Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturi...

 October 02, 2026 | News

CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis  ...

 October 01, 2026 | News

Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada

Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. With its investment throug...

 October 01, 2026 | Analysis


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close